We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+44.05%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$107M
AUM Growth
-$43.3M
Cap. Flow
-$29M
Cap. Flow %
-27.1%
Top 10 Hldgs %
87.68%
Holding
30
New
3
Increased
4
Reduced
12
Closed
8

Top Buys

Rank Stock Value
1
PHAT icon
Phathom Pharmaceuticals
PHAT
+$2.32M
2
MYGN icon
Myriad Genetics
MYGN
+$1.32M
3
CAVA icon
CAVA Group
CAVA
+$77.2K
4
FORA
Forian
FORA
+$814

Top Sells

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$7.93M
2
BHVN icon
Biohaven
BHVN
+$4.13M
3
ARDX icon
Ardelyx
ARDX
+$3.88M
4
EYPT icon
EyePoint Inc
EYPT
+$3.21M
5
PACB icon
Pacific Biosciences
PACB
+$1.88M

Sector Composition

Rank Sector Weight
1 Healthcare 85.34%
2 Consumer Discretionary 1.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PACB icon
26
CALL
Pacific Biosciences
PACB
$363M
– –
-250,000
Closed -$938K
STAA icon
27
CALL
STAAR Surgical
STAA
$1.15B
– –
-35,000
Closed -$1.34M
WBA
28
CALL
DELISTED
Walgreens Boots Alliance
WBA
– –
-410,000
Closed -$8.89M
XBI icon
29
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.1B
– –
-35,000
Closed -$3.32M
DMTK
30
DELISTED
DermTech, Inc. Common Stock
DMTK
– –
-47,687
Closed -$33.5K
1
2

Similar funds

OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM
CWA
Clearview Wealth Advisors Salem, Oregon $158M AUM 14.25% 1-Year Est. Return

Oracle Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Oracle Investment Management held 30 positions worth $107M, down 29% from $150M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Oracle Investment Management withdrew a net $29M in Q2 2024, closing 8 positions and reducing 12 holdings. Its most notable exit was Immutep, an estimated $1.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 82% a quarter earlier, followed by Consumer Discretionary.

Against the trend, Oracle Investment Management opened a new position in Phathom Pharmaceuticals worth $2.32M.

  • Oracle Investment Management's largest Q2 2024 buy was Phathom Pharmaceuticals: 225,000 shares worth $2.32M.
  • Oracle Investment Management added most to CAVA Group in Q2 2024, an estimated $77.2K increase.
  • Oracle Investment Management's biggest Q2 2024 reduction was SpringWorks Therapeutics, cutting an estimated $7.93M.
  • Oracle Investment Management fully exited Immutep in Q2 2024, selling an estimated $1.32M.
  • Oracle Investment Management's ten largest holdings make up 88% of its $107M portfolio in Q2 2024.
  • Oracle Investment Management opened 3 new positions and closed 8 in Q2 2024.
  • Oracle Investment Management's portfolio value fell 29% quarter-over-quarter to $107M.

Based on Oracle Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.